Correlations between clinical severity, genotype and muscle pathology in limb girdle muscular dystrophy type 2A

被引:26
作者
Fanin, M.
Nardetto, L.
Nascimbeni, A. C.
Tasca, E.
Spinazzi, M.
Padoan, R.
Angelini, C.
机构
[1] Venetian Inst Mol Med, I-35129 Padua, Italy
[2] Univ Padua, Dept Neurosci, Neuromuscular Ctr, I-35100 Padua, Italy
关键词
D O I
10.1136/jmg.2007.050328
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background: Limb girdle muscular dystrophy type 2A ( LGMD2A) is characterised by wide variability in clinical features and rate of progression. Patients with two null mutations usually have a rapid course, but in the remaining cases ( two missense mutations or compound heterozygote mutations) prognosis is uncertain. Methods: We conducted what is to our knowledge the first systematic histopathological, biochemical and molecular investigation of 24 LGMD2A patients, subdivided according to rapid or slow disease progression, to determine if some parameters could correlate with disease progression. Results: We found that muscle histopathology score and the extent of regenerating and degenerating fibres could be correlated with the rate of disease course when the biochemical and molecular data do not offer sufficient information. Comparison of clinical and muscle histopathological data between LGMD2A and four other types of LGMD ( LGMD2B - E) also gave another important and novel result. We found that LGMD2A has significantly lower levels of dystrophic features ( ie degenerating and regenerating fibres) and higher levels of chronic changes ( ie lobulated fibres) compared with other LGMDs, particularly LGMD2B. These results might explain the observation that atrophic muscle involvement seems to be a clinical feature peculiar to LGMD2A patients. Conclusions: Distinguishing patterns of muscle histopathological changes in LGMD2A might reflect the effects of a disease- specific pathogenetic mechanism and provide clues complementary to genetic data.
引用
收藏
页码:609 / 614
页数:6
相关论文
共 32 条
[1]   Characterization of monoclonal antibodies to calpain 3 and protein expression in muscle from patients with limb-girdle muscular dystrophy type 2A [J].
Anderson, LVB ;
Davison, K ;
Moss, JA ;
Richard, I ;
Fardeau, M ;
Tomé, FMS ;
Hübner, C ;
Lasa, A ;
Colomer, J ;
Beckmann, JS .
AMERICAN JOURNAL OF PATHOLOGY, 1998, 153 (04) :1169-1179
[2]   Calpain 3 deficiency is associated with myonuclear apoptosis and profound perturbation of the IκBα/NF-κB pathway in limb-girdle muscular dystrophy type 2A [J].
Baghdiguian, S ;
Martin, M ;
Richard, I ;
Pons, F ;
Astier, C ;
Bourg, N ;
Hay, RT ;
Chemaly, R ;
Halaby, G ;
Loiselet, J ;
Anderson, LVB ;
de Munain, AL ;
Fardeau, M ;
Mangeat, P ;
Beckmann, JS ;
Lefranc, G .
NATURE MEDICINE, 1999, 5 (05) :503-511
[3]   Calpains in muscle wasting [J].
Bartoli, M ;
Richard, I .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2005, 37 (10) :2115-2133
[4]   Calpain 3 gene mutations: genetic and clinico-pathologic findings in limb-girdle muscular dystrophy [J].
Chae, J ;
Minami, N ;
Jin, Y ;
Nakagawa, M ;
Murayama, K ;
Igarashi, F ;
Nonaka, I .
NEUROMUSCULAR DISORDERS, 2001, 11 (6-7) :547-555
[5]   Clinical variability in calpainopathy: What makes the difference? [J].
de Paula, F ;
Vainzof, M ;
Passos-Bueno, MR ;
Pavanello, RDM ;
Matioli, SR ;
Anderson, LVB ;
Nigro, V ;
Zatz, M .
EUROPEAN JOURNAL OF HUMAN GENETICS, 2002, 10 (12) :825-832
[6]  
Dubowitz V., 1985, MUSCLE BIOPSY PRACTI
[7]   Calpain 3: a key regulator of the sarcomere? [J].
Duguez, Stephanie ;
Bartoli, Marc ;
Richard, Isabelle .
FEBS JOURNAL, 2006, 273 (15) :3427-3436
[8]   Muscle pathology in dysferlin deficiency [J].
Fanin, M ;
Angelini, C .
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2002, 28 (06) :461-470
[9]   The frequency of limb girdle muscular dystrophy 2A in northeastern Italy [J].
Fanin, M ;
Nascimbeni, AC ;
Fulizio, L ;
Angelini, C .
NEUROMUSCULAR DISORDERS, 2005, 15 (03) :218-224
[10]   Molecular diagnosis in LGMD2A: Mutation analysis or protein testing? [J].
Fanin, M ;
Fulizio, L ;
Nascimbeni, AC ;
Spinazzi, M ;
Piluso, G ;
Ventriglia, VM ;
Ruzza, G ;
Siciliano, G ;
Trevisan, CR ;
Politano, L ;
Nigro, V ;
Angelini, C .
HUMAN MUTATION, 2004, 24 (01) :52-62